enGene Holdings Inc.·4

Feb 3, 4:08 PM ET

Cooper Ronald Harold Wilfred 4

4 · enGene Holdings Inc. · Filed Feb 3, 2026

Research Summary

AI-generated summary of this filing

Updated

enGene (ENGN) CEO Ronald Cooper Receives 801,000-Share Award

What Happened

  • Cooper Ronald Harold Wilfred (CEO, President & Director) received a derivative award of 801,000 shares on 2026-01-30. The filing reports an acquisition price of $0.00 (reported value $0) — this is an award/grant (transaction code A), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-01-30; Form 4 filed: 2026-02-03 (filed within the normal 2-business-day window).
  • Shares/units granted: 801,000; reported acquisition price: $0.00; reported cash value: $0 (derivative award).
  • Shares owned after transaction: not specified in the Form 4 (not disclosed in the filing).
  • Vesting note (from filing): the award vests monthly in substantially equal amounts over 48 months, subject to continued service.
  • Transaction type: A = award/grant (derivative); not an exercise, sale, or purchase.

Context

  • This is a compensation award that will convert to actual shares only as the units vest; there is no immediate cash outlay and no immediate change in tradable shares. Grants are common for executive compensation and reflect potential future ownership tied to ongoing service — they are not equivalent to a market purchase that might signal immediate insider conviction.

Insider Transaction Report

Form 4
Period: 2026-01-30
Cooper Ronald Harold Wilfred
DirectorCEO & President
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2026-01-30+801,000801,000 total
    Exercise: $9.53Exp: 2036-01-30Common Shares (801,000 underlying)
Footnotes (1)
  • [F1]This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service.
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person|2026-02-03

Documents

1 file
  • 4
    form4.xmlPrimary